Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining 0.84% today. In the last week its performance is -2.10%, and 5.76% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 70, so today’s gain of 0.84% is a significant step towards its target price. The GAP today is therefore -0.11%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 103042.52, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 70.90%.
At the current price of 63.94, it has a dividend yield of 3.60%, and its target price is 70. This is with a profit margin of 23.00%, and total debt/equity of 6.87. AbbVie Inc. (NYSE:ABBV) has a P/E of 19, as well as a forward P/E of 11.3.
With a current EPS of 3.34, and a forecasted EPS growth for next year at 17.85%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 16.34%.
Performance for the year is -6.63%. Since its IPO date on 1/2/2013, the total performance to date is 10.16%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 3747873, while its average volume is 9189.35. Whilst the total gain today was 0.84%, it did have a day high of -1.98%.
Volatility for this week has been at 1.36%, and 1.78% for the month. The 52-week low for AbbVie Inc., ABBV has been 44.80%, while the 52-week-high has reached -7.24%.
Looking at its return of investments, which is 16.90%, and its return on assets is 10.20%. AbbVie Inc. (NYSE:ABBV) has an operating margin of 34.20%. With a sales growth of 18.20% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is 6.35, and has a current ratio of 1.6 and 1.4 for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.16, and the P/S is 4.33, along with a P/B of 22.09. Meanwhile it has a p/cash of 11.98.